Form 8-K - Current report:
SEC Accession No. 0001558370-19-010162
Filing Date
2019-11-06
Accepted
2019-11-06 16:08:50
Documents
14
Period of Report
2019-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axgn-20191106x8k01fc50c.htm   iXBRL 8-K 40001
2 EX-99.1 ex-99d1.htm EX-99.1 586466
3 GRAPHIC ex-99d1g001.jpg GRAPHIC 30876
  Complete submission text file 0001558370-19-010162.txt   817195

Data Files

Seq Description Document Type Size
4 EX-101.SCH axgn-20191106.xsd EX-101.SCH 3265
5 EX-101.LAB axgn-20191106_lab.xml EX-101.LAB 16166
6 EX-101.PRE axgn-20191106_pre.xml EX-101.PRE 10942
7 EXTRACTED XBRL INSTANCE DOCUMENT axgn-20191106x8k01fc50c_htm.xml XML 4846
Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
Axogen, Inc. (Filer) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36046 | Film No.: 191196360
SIC: 3845 Electromedical & Electrotherapeutic Apparatus